{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T22:44:21Z","timestamp":1793400261634,"version":"4.5.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,3,20]],"date-time":"2024-03-20T00:00:00Z","timestamp":1710892800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,3,20]],"date-time":"2024-03-20T00:00:00Z","timestamp":1710892800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Pain Headache Rep"],"published-print":{"date-parts":[[2024,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose of Review<\/jats:title>\n                    <jats:p>The opioid epidemic has been responsible for significant morbidity and mortality in the USA and worldwide. As a result, it is essential to recognize the threat these potent drugs can cause when illicitly used. Specifically, introducing fentanyl as a drug adulterant has been shown to impact overdose rates drastically. In this regard, the Drug Enforcement Agency recently released a public safety alert announcing the new threat of a new adulterant called xylazine. Xylazine is a powerful animal sedative with a different mechanism of action when compared to illicit opioids such as heroin and fentanyl. Xylazine is typically injected intravenously via a syringe, often in combination with multiple other drugs. One of the most common drugs, xylazine, is taken in combination with fentanyl, with users of this drug combination describing xylazine as prolonging the euphoric sensation produced by fentanyl.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Recent Findings<\/jats:title>\n                    <jats:p>Xylazine may cause adverse effects such as bradycardia, brief hypertension followed by hypotension, premature ventricular contractions, ataxia, slurred speech, sedation, and respiratory depression. Much of the recent literature on xylazine use in humans comes from case reports and review articles.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>Related to widespread use in veterinary medicine and increasing circulation in illicit drug markets, there is a critical need for public awareness and additional clinical-based studies to further increase understanding of mediated or modulated pharmacological effects of xylazine in humans. Further research is urgently needed to more clearly understand the implications of unregulated xylazine in the illicit drug market, to formulate public health interventions, and to implement harm reduction strategies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11916-024-01211-z","type":"journal-article","created":{"date-parts":[[2024,3,20]],"date-time":"2024-03-20T06:03:37Z","timestamp":1710914617000},"page":"417-426","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":61,"title":["Xylazine: A Drug Adulterant of Clinical Concern"],"prefix":"10.1007","volume":"28","author":[{"given":"Amber N.","family":"Edinoff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saveen","family":"Sall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William C.","family":"Upshaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noah J.","family":"Spillers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LeighAnn Y.","family":"Vincik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adalyn S.","family":"De Witt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin S.","family":"Murnane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam M.","family":"Kaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan D.","family":"Kaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,20]]},"reference":[{"key":"1211_CR1","unstructured":"Schiller EY, Goyal A, Mechanic OJ. Opioid overdose. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 [cited 2023 Aug 6]. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK470415\/."},{"key":"1211_CR2","unstructured":"National Institute on Drug Abuse [Internet]. 2023 [cited 2023 Aug 6]. Drug overdose death rates. Available from: https:\/\/nida.nih.gov\/research-topics\/trends-statistics\/overdose-death-rates."},{"key":"1211_CR3","unstructured":"Reported law enforcement encounters testing positive for fentanyl increase across US | Drug overdose | CDC Injury Center [Internet]. 2023 [cited 2023 Aug 6]. Available from: https:\/\/www.cdc.gov\/drugoverdose\/deaths\/fentanyl-encounters\/index.html."},{"issue":"1","key":"1211_CR4","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s40122-018-0097-6","volume":"7","author":"MR Jones","year":"2018","unstructured":"Jones MR, Viswanath O, Peck J, Kaye AD, Gill JS, Simopoulos TT. A brief history of the opioid epidemic and strategies for pain medicine. Pain Ther. 2018;7(1):13\u201321.","journal-title":"Pain Ther"},{"issue":"6","key":"1211_CR5","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1007\/s11916-019-0781-1","volume":"23","author":"MR Jones","year":"2019","unstructured":"Jones MR, Novitch MB, Sarrafpour S, Ehrhardt KP, Scott BB, Orhurhu V, et al. Government legislation in response to the opioid epidemic. Curr Pain Headache Rep. 2019;23(6):40.","journal-title":"Curr Pain Headache Rep"},{"key":"1211_CR6","unstructured":"DEA reports widespread threat of fentanyl mixed with xylazine | DEA.gov [Internet]. [cited 2023 Aug 6]. Available from: https:\/\/www.dea.gov\/alert\/dea-reports-widespread-threat-fentanyl-mixed-xylazine."},{"key":"1211_CR7","unstructured":"AP News [Internet]. 2023 [cited 2023 Aug 6]. Animal sedative xylazine in fentanyl is causing wounds and scrambling efforts to stop overdoses. Available from: https:\/\/apnews.com\/article\/xylazine-tranquilizer-animal-sedative-opioids-overdose-eabdd7332f309e9e9b610db0c2c9922c."},{"key":"1211_CR8","unstructured":"Underlying cause of death, 1999\u20132020 Request [Internet]. [cited 2023 Aug 5]. Available from: https:\/\/wonder.cdc.gov\/ucd-icd10.html."},{"key":"1211_CR9","unstructured":"National Institute on Drug Abuse [Internet]. 2021 [cited 2023 Aug 5]. Fentanyl drugfacts. Available from: https:\/\/nida.nih.gov\/publications\/drugfacts\/fentanyl."},{"key":"1211_CR10","unstructured":"Centers for Disease Control and Prevention [Internet]. 2023 [cited 2023 Aug 5]. Other drugs. Available from: https:\/\/www.cdc.gov\/drugoverdose\/deaths\/other-drugs.html."},{"issue":"2","key":"1211_CR11","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1002\/dta.220","volume":"3","author":"C Cole","year":"2011","unstructured":"Cole C, Jones L, McVeigh J, Kicman A, Syed Q, Bellis M. Adulterants in illicit drugs: a review of empirical evidence. Drug Test Anal. 2011;3(2):89\u201396.","journal-title":"Drug Test Anal"},{"issue":"1","key":"1211_CR12","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1177\/0033354919887741","volume":"135","author":"VM Singh","year":"2019","unstructured":"Singh VM, Browne T, Montgomery J. The emerging role of toxic adulterants in street drugs in the US illicit opioid crisis. Public Health Rep. 2019;135(1):6\u201310.","journal-title":"Public Health Rep"},{"issue":"3","key":"1211_CR13","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1111\/1556-4029.13968","volume":"64","author":"TR Fiorentin","year":"2019","unstructured":"Fiorentin TR, Krotulski AJ, Martin DM, Browne T, Triplett J, Conti T, et al. Detection of cutting agents in drug-positive seized exhibits within the United States. J Forensic Sci. 2019;64(3):888\u201396.","journal-title":"J Forensic Sci"},{"issue":"12","key":"1211_CR14","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1007\/s11606-012-2089-2","volume":"27","author":"KA Phillips","year":"2012","unstructured":"Phillips KA, Hirsch GA, Epstein DH, Preston KL. Cardiac complications of unwitting co-injection of quinine\/quinidine with heroin in an intravenous drug user. J Gen Intern Med. 2012;27(12):1722\u20135.","journal-title":"J Gen Intern Med"},{"key":"1211_CR15","unstructured":"Ramos-Matos CF, Bistas KG, Lopez-Ojeda W. Fentanyl. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 [cited 2023 Aug 5]. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK459275\/."},{"key":"1211_CR16","unstructured":"Fentanyl\u2019s rise on darknet markets (and how to stop it) [Internet]. Chicago Policy Review. 2020 [cited 2023 Aug 5]. Available from: https:\/\/chicagopolicyreview.org\/2020\/08\/10\/fentanyls-rise-on-darknet-markets-and-how-to-stop-it\/."},{"key":"1211_CR17","doi-asserted-by":"crossref","unstructured":"Scholl L. Drug and opioid-involved overdose deaths \u2014 United States, 2013\u20132017. MMWR Morb Mortal Wkly Rep [Internet]. 2019 [cited 2023 Aug 5];67. Available from: https:\/\/www.cdc.gov\/mmwr\/volumes\/67\/wr\/mm675152e1.htm.","DOI":"10.15585\/mmwr.mm675152e1"},{"issue":"60","key":"1211_CR18","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.drugpo.2018.08.004","volume":"1","author":"C McKnight","year":"2018","unstructured":"McKnight C, Des Jarlais DC. Being \u201chooked up\u201d during a sharp increase in the availability of illicitly manufactured fentanyl: adaptations of drug using practices among people who use drugs (PWUD) in New York City. Int J Drug Policy. 2018;1(60):82\u20138.","journal-title":"Int J Drug Policy"},{"key":"1211_CR19","unstructured":"Krishnan M. A horrifying drug called \u2018tranq dope\u2019 is spreading in the US [Internet]. Vice. 2022 [cited 2023 Aug 5]. Available from: https:\/\/www.vice.com\/en\/article\/akeqje\/tranq-dope-in-united-states."},{"issue":"3","key":"1211_CR20","first-page":"519","volume":"89","author":"JC Reyes","year":"2012","unstructured":"Reyes JC, Negr\u00f3n JL, Col\u00f3n HM, Padilla AM, Mill\u00e1n MY, Matos TD, et al. The emerging of xylazine as a new drug of abuse and its health consequences among drug users in Puerto Rico. J Urban Health Bull N Y Acad Med. 2012;89(3):519\u201326.","journal-title":"J Urban Health Bull N Y Acad Med"},{"issue":"233","key":"1211_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2022.109380","volume":"1","author":"J Friedman","year":"2022","unstructured":"Friedman J, Montero F, Bourgois P, Wahbi R, Dye D, Goodman-Meza D, et al. Xylazine spreads across the US: a growing component of the increasingly synthetic and polysubstance overdose crisis. Drug Alcohol Depend. 2022;1(233):109380.","journal-title":"Drug Alcohol Depend"},{"key":"1211_CR22","doi-asserted-by":"crossref","unstructured":"Khatri SN, Sadek S, Kendrick PT, Bondy EO, Hong M, Pauss S, et al. Xylazine suppresses fentanyl consumption during self-administration and induces a unique sex-specific withdrawal syndrome that is not altered by naloxone in rats. Exp Clin Psychopharmacol. 2023.","DOI":"10.1101\/2023.05.17.541158"},{"issue":"4","key":"1211_CR23","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1093\/jat\/25.4.245","volume":"25","author":"U Hoffmann","year":"2001","unstructured":"Hoffmann U, Meister CM, Golle K, Zschiesche M. Severe intoxication with the veterinary tranquilizer xylazine in humans. J Anal Toxicol. 2001;25(4):245\u20139.","journal-title":"J Anal Toxicol"},{"key":"1211_CR24","unstructured":"National Institute on Drug Abuse [Internet]. 2022 [cited 2023 Aug 6]. Xylazine. Available from: https:\/\/nida.nih.gov\/research-topics\/xylazine."},{"issue":"240","key":"1211_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.forsciint.2014.03.015","volume":"1","author":"K Ruiz-Col\u00f3n","year":"2014","unstructured":"Ruiz-Col\u00f3n K, Chavez-Arias C, D\u00edaz-Alcal\u00e1 JE, Mart\u00ednez MA. Xylazine intoxication in humans and its importance as an emerging adulterant in abused drugs: a comprehensive review of the literature. Forensic Sci Int. 2014;1(240):1\u20138.","journal-title":"Forensic Sci Int"},{"issue":"2","key":"1211_CR26","doi-asserted-by":"publisher","first-page":"R287","DOI":"10.1152\/ajpregu.00123.2002","volume":"283","author":"M Philipp","year":"2002","unstructured":"Philipp M, Brede M, Hein L. Physiological significance of \u03b12-adrenergic receptor subtype diversity: one receptor is not enough. Am J Physiol-Regul Integr Comp Physiol. 2002;283(2):R287\u201395.","journal-title":"Am J Physiol-Regul Integr Comp Physiol"},{"issue":"3","key":"1211_CR27","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1152\/physrev.1983.63.3.844","volume":"63","author":"SL Foote","year":"1983","unstructured":"Foote SL, Bloom FE, Aston-Jones G. Nucleus locus ceruleus: new evidence of anatomical and physiological specificity. Physiol Rev. 1983;63(3):844\u2013914.","journal-title":"Physiol Rev"},{"issue":"5","key":"1211_CR28","doi-asserted-by":"publisher","first-page":"3033","DOI":"10.1073\/pnas.77.5.3033","volume":"77","author":"SL Foote","year":"1980","unstructured":"Foote SL, Aston-Jones G, Bloom FE. Impulse activity of locus coeruleus neurons in awake rats and monkeys is a function of sensory stimulation and arousal. Proc Natl Acad Sci U S A. 1980;77(5):3033\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1211_CR29","unstructured":"Taylor BN, Cassagnol M. Alpha-adrenergic receptors. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 [cited 2023 Aug 6]. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK539830\/."},{"issue":"2","key":"1211_CR30","first-page":"153","volume":"186","author":"WH Hsu","year":"1985","unstructured":"Hsu WH, Lu ZX, Hembrough FB. Effect of xylazine on heart rate and arterial blood pressure in conscious dogs, as influenced by atropine, 4-aminopyridine, doxapram, and yohimbine. J Am Vet Med Assoc. 1985;186(2):153\u20136.","journal-title":"J Am Vet Med Assoc"},{"issue":"24","key":"1211_CR31","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1056\/NEJMp2303120","volume":"388","author":"R Gupta","year":"2023","unstructured":"Gupta R, Holtgrave DR, Ashburn MA. Xylazine \u2014 medical and public health imperatives. N Engl J Med. 2023;388(24):2209\u201312.","journal-title":"N Engl J Med"},{"issue":"2","key":"1211_CR32","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1111\/j.1365-2885.1981.tb00715.x","volume":"4","author":"R Garcia-Villar","year":"1981","unstructured":"Garcia-Villar R, Toutain PL, Alvinerie M, Ruckebusch Y. The pharmacokinetics of xylazine hydrochloride: an interspecific study. J Vet Pharmacol Ther. 1981;4(2):87\u201392.","journal-title":"J Vet Pharmacol Ther"},{"issue":"4","key":"1211_CR33","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.jemermed.2006.02.042","volume":"30","author":"LI Velez","year":"2006","unstructured":"Velez LI, Shepherd G, Mills LD, Rivera W. Systemic toxicity after an ocular exposure to xylazine hydrochloride. J Emerg Med. 2006;30(4):407\u201310.","journal-title":"J Emerg Med"},{"key":"1211_CR34","unstructured":"The pharmacokinetics of xylazine hydrochloride: an interspecific study - GARCIA\u2010VILLAR - 1981 - Journal of Veterinary Pharmacology and Therapeutics - Wiley Online Library [Internet]. [cited 2023 Aug 6]. Available from: https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2885.1981.tb00715.x."},{"key":"1211_CR35","unstructured":"Mansoor A, Mahabadi N. Volume of distribution. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 [cited 2023 Aug 6]. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK545280\/."},{"issue":"3","key":"1211_CR36","doi-asserted-by":"publisher","first-page":"281","DOI":"10.3109\/15563657908989878","volume":"15","author":"SG Carruthers","year":"1979","unstructured":"Carruthers SG, Nelson M, Wexler HR, Stiller CR. Xylazine hydrochloridine (Rompun) overdose in man. Clin Toxicol. 1979;15(3):281\u20135.","journal-title":"Clin Toxicol"},{"issue":"30","key":"1211_CR37","doi-asserted-by":"publisher","first-page":"9779","DOI":"10.1007\/s00216-013-7419-7","volume":"405","author":"GMJ Meyer","year":"2013","unstructured":"Meyer GMJ, Maurer HH. Qualitative metabolism assessment and toxicological detection of xylazine, a veterinary tranquilizer and drug of abuse, in rat and human urine using GC\u2013MS, LC\u2013MSn, and LC\u2013HR-MSn. Anal Bioanal Chem. 2013;405(30):9779\u201389.","journal-title":"Anal Bioanal Chem"},{"issue":"3","key":"1211_CR38","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1080\/15563650601073520","volume":"45","author":"CM Liu","year":"2007","unstructured":"Liu CM, Chiu MJ, Fang CC, Chen WJ. Letter to the editor: \u201cXylazine abuse: a rare cause of syncope.\u201d Clin Toxicol. 2007;45(3):309\u201311.","journal-title":"Clin Toxicol"},{"key":"1211_CR39","doi-asserted-by":"crossref","unstructured":"Malayala SV, Papudesi BN, Bobb R, Wimbush A. Xylazine-induced skin ulcers in a person who injects drugs in Philadelphia, Pennsylvania, USA. Cureus [Internet]. 2022 Aug 19 [cited 2023 Aug 6]; Available from: https:\/\/www.cureus.com\/articles\/98408-xylazine-induced-skin-ulcers-in-a-person-who-injects-drugs-in-philadelphia-pennsylvania-usa.","DOI":"10.7759\/cureus.28160"},{"key":"1211_CR40","unstructured":"Soderquist M, Delgado G, Abdelfattah H, Thoder J, Solarz M. Necrotic upper-extremity infections in people who inject drugs: a case series. J Hand Surg [Internet]. 2023 May 12 [cited 2023 Aug 6];0(0). Available from: https:\/\/www.jhandsurg.org\/article\/S0363-5023(23)00177-6\/fulltext."},{"issue":"5276","key":"1211_CR41","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1126\/science.273.5276.803","volume":"273","author":"RE Link","year":"1996","unstructured":"Link RE, Desai K, Hein L, Stevens ME, Chruscinski A, Bernstein D, et al. Cardiovascular regulation in mice lacking alpha2-adrenergic receptor subtypes b and c. Science. 1996;273(5276):803\u20135.","journal-title":"Science"},{"issue":"6","key":"1211_CR42","doi-asserted-by":"publisher","first-page":"663","DOI":"10.3109\/15563658108990293","volume":"18","author":"AG Gallanosa","year":"1981","unstructured":"Gallanosa AG, Spyker DA, Shipe JR, Morris DL. Human xylazine overdose: a comparative review with clonidine, phenothiazines, and tricyclic antidepressants. Clin Toxicol. 1981;18(6):663\u201378.","journal-title":"Clin Toxicol"},{"issue":"37","key":"1211_CR43","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.15585\/mmwr.mm7037a5","volume":"70","author":"S Thangada","year":"2021","unstructured":"\u2022 Thangada S, Clinton HA, Ali S, Nunez J, Gill JR, Lawlor RF, et al. Notes from the field: xylazine, a veterinary tranquilizer, identified as an emerging novel substance in drug overdose deaths \u2014 Connecticut, 2019\u20132020. Morb Mortal Wkly Rep. 2021;70(37):1303\u20135.\u00a0This study showed the overdose deaths as linked to xylazine in CT over a period of time, which showed that xylazine was present in the drug supply and overdose deaths.","journal-title":"Morb Mortal Wkly Rep"},{"issue":"7","key":"1211_CR44","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1093\/jat\/bkw051","volume":"40","author":"FP Busard\u00f2","year":"2016","unstructured":"Busard\u00f2 FP, Pichini S, Pacifici R, Karch SB. The never-ending public health issue of adulterants in abused drugs. J Anal Toxicol. 2016;40(7):561\u20132.","journal-title":"J Anal Toxicol"},{"issue":"6","key":"1211_CR45","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1097\/00006565-200112000-00012","volume":"17","author":"AJ Capraro","year":"2001","unstructured":"Capraro AJ, Wiley JF, Tucker JR. Severe intoxication from xylazine inhalation. Pediatr Emerg Care. 2001;17(6):447\u20138.","journal-title":"Pediatr Emerg Care"},{"key":"1211_CR46","unstructured":"Jordan MR, Morrisonponce D. Naloxone. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 [cited 2023 Aug 6]. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK441910\/."},{"key":"1211_CR47","doi-asserted-by":"crossref","unstructured":"Johnson J,\u00a0Pizzicato L,\u00a0Johnson C, Viner K. Increasing presence of xylazine in heroin and\/or fentanyl deaths, Philadelphia, Pennsylvania, 2010\u20132019 | Injury Prevention [Internet]. [cited 2023 Sep 28]. Available from: https:\/\/injuryprevention.bmj.com\/content\/27\/4\/395.long.","DOI":"10.1136\/injuryprev-2020-043968"},{"key":"1211_CR48","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.cca.2021.07.010","volume":"521","author":"WR Korn","year":"2021","unstructured":"\u2022 Korn WR, Stone MD, Haviland KL, Toohey JM, Stickle DF. High prevalence of xylazine among fentanyl screen-positive urines from hospitalized patients, Philadelphia, 2021. Clin Chim Acta Int J Clin Chem. 2021;521:151\u20134.\u00a0This study was important as it showed the prevalence of xylazine in patients that that had a positive fentanyl screen.","journal-title":"Clin Chim Acta Int J Clin Chem"},{"issue":"26","key":"1211_CR49","doi-asserted-by":"publisher","first-page":"721","DOI":"10.15585\/mmwr.mm7226a4","volume":"72","author":"M Kariisa","year":"2023","unstructured":"Kariisa M, O\u2019Donnell J, Kumar S, Mattson CL, Goldberger BA. Illicitly manufactured fentanyl\u2013involved overdose deaths with detected xylazine \u2014 United States, January 2019\u2013June 2022. Morb Mortal Wkly Rep. 2023;72(26):721\u20137.","journal-title":"Morb Mortal Wkly Rep"},{"issue":"3","key":"1211_CR50","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1111\/ajad.13365","volume":"32","author":"J Sibbesen","year":"2023","unstructured":"Sibbesen J, Abate MA, Dai Z, Smith GS, Lundstrom E, Kraner JC, et al. Characteristics of xylazine-related deaths in West Virginia\u2014Xylazine-related deaths. Am J Addict. 2023;32(3):309\u201313.","journal-title":"Am J Addict"},{"issue":"249","key":"1211_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2023.110833","volume":"1","author":"C Delcher","year":"2023","unstructured":"Delcher C, Anthony N, Mir M. Xylazine-involved fatal overdoses and localized geographic clustering: Cook County, IL, 2019\u20132022. Drug Alcohol Depend. 2023;1(249): 110833.","journal-title":"Drug Alcohol Depend"},{"issue":"4","key":"1211_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.dadr.2022.100074","volume":"30","author":"MK Reed","year":"2022","unstructured":"Reed MK, Imperato NS, Bowles JM, Salcedo VJ, Guth A, Rising KL. Perspectives of people in Philadelphia who use fentanyl\/heroin adulterated with the animal tranquilizer xylazine; making a case for xylazine test strips. Drug Alcohol Depend Rep. 2022;30(4): 100074.","journal-title":"Drug Alcohol Depend Rep"},{"issue":"3","key":"1211_CR53","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1080\/15563650.2022.2159427","volume":"61","author":"JS Love","year":"2023","unstructured":"Love JS, Levine M, Aldy K, Brent J, Krotulski AJ, Logan BK, et al. Opioid overdoses involving xylazine in emergency department patients: a multicenter study. Clin Toxicol Phila Pa. 2023;61(3):173\u201380.","journal-title":"Clin Toxicol Phila Pa"},{"key":"1211_CR54","doi-asserted-by":"crossref","unstructured":"Ayub S, Parnia S, Poddar K, Bachu AK, Sullivan A, Khan AM, et al. Xylazine in the opioid epidemic: a systematic review of case reports and clinical implications. Cureus. 2023;15(3):e36864.","DOI":"10.7759\/cureus.36864"},{"issue":"2","key":"1211_CR55","doi-asserted-by":"publisher","first-page":"119","DOI":"10.4103\/tjem.tjem_198_22","volume":"23","author":"LK Choon","year":"2023","unstructured":"\u2022 Choon LK, Khiruddin AI, Annuar WMWM, Shamsuddin SR. A case series of accidental xylazine intoxication in humans; is there a role of naloxone as an antidote? Turk J Emerg Med. 2023;23(2):119\u201322.\u00a0This study highlights that naloxone doesn\u2019t have a role in treated xylazine related overdoses.","journal-title":"Turk J Emerg Med"},{"issue":"5","key":"1211_CR56","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1097\/ADM.0000000000000955","volume":"16","author":"R Ehrman-Dupre","year":"2022","unstructured":"Ehrman-Dupre R, Kaigh C, Salzman M, Haroz R, Peterson LK, Schmidt R. Management of xylazine withdrawal in a hospitalized patient: a case report. J Addict Med. 2022;16(5):595\u20138.","journal-title":"J Addict Med"}],"container-title":["Current Pain and Headache Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11916-024-01211-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11916-024-01211-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11916-024-01211-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T12:55:14Z","timestamp":1731588914000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11916-024-01211-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,20]]},"references-count":56,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["1211"],"URL":"https:\/\/doi.org\/10.1007\/s11916-024-01211-z","relation":{},"ISSN":["1531-3433","1534-3081"],"issn-type":[{"value":"1531-3433","type":"print"},{"value":"1534-3081","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,20]]},"assertion":[{"value":"8 January 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors have no conflict of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"All reported studies\/experiments with human or animal subjects performed by the authors have been previously published and complied with all applicable ethical standards (including the Helsinki declaration and its amendments, institutional\/national research committee standards, and international\/national\/institutional guidelines).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}]}}